Gilead Sciences, Inc.
NASDAQ: GILD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Daniel O'Day
- Employees
- 17,600
- Headquarters
- Foster City, United States
- IPO year
- 1992
- Market cap
- $156.4B
- Website
- https://www.gilead.com
Loading GILD…
Loading profile data…Frequently asked questions about GILD
What does Gilead Sciences, Inc. (GILD) do?
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments fo...
Where does GILD trade?
Gilead Sciences, Inc. (GILD) trades on the NASDAQ Global Select.
What sector is GILD in?
Gilead Sciences, Inc. (GILD) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Gilead Sciences, Inc.?
Daniel O'Day is the chief executive officer of Gilead Sciences, Inc. (GILD).
Where is Gilead Sciences, Inc. headquartered?
Gilead Sciences, Inc. is headquartered in United States.
When did GILD go public?
Gilead Sciences, Inc. (GILD) completed its initial public offering in 1992.